Recall Alert: 600,000 Blood Pressure Pills Pulled Over Contamination Risk

The U.S. Food and Drug Administration (FDA) has recalled more than 600,000 bottles of the blood pressure drug ramipril after finding possible contamination linked to an unlicensed factory in India.

Over 2.4 million Americans take ramipril each year to help lower blood pressure by relaxing blood vessels and improving heart health. The recall has caused concern for both patients and doctors.

Ramipril, made by Lupin Pharmaceuticals, is sold in three strengths: 2.5 mg, 5 mg, and 10 mg, in bottles of 90, 100, or 500 capsules. The affected products expire in July 2026. The first recall, announced in October, covered only the 5 mg and 10 mg strengths. On November 19, the FDA expanded it to include the 2.5 mg version.

This raised concerns about safety and quality in the drug supply chain. The FDA labeled the recall as Class II, meaning there is a low risk of serious injury or death, but still stressed the need for strict quality control. The contamination is believed to involve tiny amounts of chemicals that could be harmful if taken for a long time. The exact substances have not been disclosed.